Reorganization of actin in K-562 and HL-60 cells treated with taxol

Neoplasma

Volumn 53, Issue 1, 2006, Pages 56-61

  Grzanka, A ^a   Grzanka, D ^a   Zuryn A ^a   Grzanka, A A ^a   Safiejko Mroczka, B ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Actin; Apoptosis; HL 60; Immunogold method; K 562; Taxol

Indexed keywords

ACTIN; F ACTIN; GOLD; PACLITAXEL; PHALLOIDIN; RHODAMINE; STREPTAVIDIN;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CANCER CELL; CELL NUCLEUS; CELL STRAIN HL 60; CELL STRAIN K 562; CELL ULTRASTRUCTURE; CHROMATIN STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DRUG MECHANISM; DRUG TARGETING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; MICROTUBULE ASSEMBLY; PROTEIN LOCALIZATION;

EID: 32144435752     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ABERCROMBIE M. The crawling movement of metazoan cells. Proc R Soc Lond B Biol Sci 1980; 207: 129-147.
2. CARLIER MF, RESSAD F, PANTALONI D. Control of actin dynamics in cell motility. Role of ADF/cofilin. J Biol Chem 1999; 274: 33827-33830.
3. BANDO M, MIYAKE Y, SHIINA M, WACHI M, NAGAI K et al. Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells. Biochem Biophys Res Commun 2002; 290: 268-274.
4. BROWN SB, BAILEY K, SAVILL J. Actin is cleaved during constitutive apoptosis. Biochem J 1997; 323: 233-237.
5. COTTER TG, LENNON SV, GLYNN JM, GREEN DR. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992; 52: 997-1005.
6. GRZANKA A. Actin distribution patterns in HL-60 leukemia cells treated with etoposide. Acta Histochem 2001a; 103: 453-464.
7. GRZANKA A, GRZANKA D, ORLIKOWSKA M. Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem Pharmacol 2003; 66: 1611-1617.
8. LEVEE MG, DABROWSKA MI, LELLI JL, HINSHAW DB. Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 1996; 271: C1981-C1992.
9. VESELSKA R, ZITTERBART K, JELINKOVA S, NERADIL J, SVOBODA A. Specific cytoskeleton changes during apoptosis accompanying induced differentiation of HL-60 myeloid leukaemia cells. Oncology Rep 2003; 10: 1049-1058.
10. WHITE SR, WILLIAMS P, WOJCIK KR, SUN S, HIEMSTRA PS et al. Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24: 282-294.
11. RANDO OJ, ZHAO K, CRABTREE GR. Searching for a function for nuclear actin. Trends Cell Biol 2000; 10: 92-97.
12. AMANKWAH KS, DE BONI U. Ultrastructural localization of filamentous actin within neuronal interphase nuclei in situ. Exp Cell Res 1994; 210: 315-325.
13. BASSELL GJ, TANEJA KL, KISLAUSKIS EH, SUNDELL CL, POWERS CM et al. Actin filaments and the spatial positioning of mRNAS. Adv Exp Med Biol 1994; 358: 183-189.
14. FUNAKI K, KATSUMOTO T, IINO A. Immunocytochemical localization of actin in the nucleolus of rat oocytes. Biol Cell 1995; 84: 139-146.
15. MILANKOV K, DE BONI U. Cytochemical localization of actin and myosin aggregates in interphase nuclei in situ. Exp Cell Res 1993; 209: 189-199.
16. NAKAYASU H, UEDA K. Association of actin with the nuclear matrix from bovine lymphocytes. Exp Cell Res 1983; 143: 55-62.
17. PARFENOV VN, GALAKTIONOV KI. Intranuclear actin microfilaments in the oocytes of the common frog. Tsitologiia 1987; 29: 142-149.
18. SAUMAN I, BERRY SJ. An actin infrastructure is associated with eukaryotic chromosomes: structural and functional significance. Eur J Cell Biol 1994; 64: 348-356.
19. PERCIPALLE P, ZHAO J, POPE B, WEEDS A, LINDBERG U, DANEHOLT B. Actin bound to the heterogeneous nuclear ribonucleoprotein hrp36 is associated with Balbiani ring mRNA from the gene to polysomes. J Cell Biol 2001; 153: 229-236.
20. PUCK KK, KRYSTOSEK A. Role of cytoskeleton in genome regulation and cancer. Int Rev Cytol 1992; 132: 75-108.
21. ZHAO K, WANG W, RANDO OJ, XUE Y, SWIDEREK K et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 1998; 95: 625-636.
22. GONSIOR SM, PLATZ S, BUCHMEIER S, SCHEER U, JOCKUSCH BM, HINSSEN H. Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci 1999; 112: 797-809.
23. MANFREDI JJ, PARNESS J, HORWITZ SB. Taxol binds to cellular microtubules. J Cell Biol 1982; 94: 688-696.
24. PARNESS J, HORWITZ SB. Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981; 91: 479-487.
25. SCHIFF PB, HORWITZ SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561-1565.
26. BLAGOSKLONNY MV, ROBEY R, SHEIKH MS, FOJO T. Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death. Cancer Biol Ther 2002; 1: 113-117.
27. FAN W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 1999; 57: 1215-1221.
28. IRELAND CM, PITTMAN SM. Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs. Biochem Pharmacol 1995; 49: 1491-1499.
29. LONG BH, FAIRCHILD CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 1994; 54: 4355-4361.
30. BONNETERRE J, TUBIANA-HULIN M, CATIMEL G. Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study. Oncology 2004; 66: 185-191.
31. EISENHAUER EA, VERMORKEN JB. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 1998; 55: 5-30.
32. LIEBMANN JE, COOK JA, LIPSCHULTZ C, TEAGUE D, FISHER J, MITCHELL JB. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer 1993; 68: 1104-1109.
33. WISEMAN LR, SPENCER CM. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers. Drugs Aging 1998; 12: 305-334.
34. RODRIGUEZ OC, SCHAEFEWR AW, MANDATO CA, FORSCHER P BEMENT WM, WATERMAN-STORER CM. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 2003; 5: 599-609.
35. GRZANKA A, GRZANKA D. Distribution of actin in etoposide-induced human leukemia cell line K-562 using fluorescence and immunoelectron microscopy technique. Pol J Pathology 2002; 53: 43-50.
36. JORDAN A, HADFIELD JA, LAWRENCE NJ, McGOWN AT. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998; 4: 259-296.
37. SHI Q, CHEN K, MORRIS-NATSCHKE SL, LEE KH. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr Pharm Des 1998; 4: 219-248.
38. JORDAN MA, WILSON L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998; 10: 123-130.
39. GRZANKA A. Estimation of changes in tubulin induced with etoposide in human leukemia cells line K-562 by immunofluorescence microscope. Neoplasma 2001b; 48: 48-51.
40. GRZANKA A. Estimation of changes in vimentin filaments induced by etoposide and doxorubicin in human leukemia cell line K-562 by using immunofluorescence microscopy. Neoplasma 2001c; 48: 285-289.
41. GRZANKA A, GRZANKA D. The influence of etoposide on the distribution of tubulin in human leukaemia cell line Hl-60. Med Sci Monit 2003; 9: BR66-9.
42. ROWINSKY EK, CAZENNAVE LA, DONEHOWER RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82: 1247-1259.
43. BLANCAFLOR EB. Cortical actin filaments potentially interact with cortical microtubules in regulating polarity of cell expansion in primary roots of maize (Zea mays L.). J Plant Growth Regul 2000; 19: 406-414.
44. LU Y, JAMIESON L, BRASIER AR, FIELDS AP. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene 2001; 20: 4777-4792.
45. WAN YF, GUO XQ, WANG ZH, YING K, YAO MH. Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin 2004; 25: 378-384.
46. GANGEMI RM, TISO M, MARCHETTI C, SEVERI AB, FABBI M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 1995; 36: 385-392.
47. RAO JY, LI N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004; 4: 345-354.